1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TFF PHARMACEUTICALS INC

Tff Pharmaceuticals Inc

XNAS: TFFP

Watchlist

Portfolio

Share


Insider Trading disclosures for Tff Pharmaceuticals Inc

The latest disclosure was made by Robert S. Mills in Tff Pharmaceuticals Inc where a trade of 3,165 Stock Options (Right to Buy) done was reported to US exchanges on July 3, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Robert S. Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 3,165 3,165 - - Stock Options (Right to Buy)
Robert S. Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 3,165 59,145 (0%) 0% 0 Common Stock
Stephen C. Rocamboli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 3,165 39,165 (0%) 0% 0 Common Stock
Stephen C. Rocamboli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 3,165 3,165 - - Stock Options (Right to Buy)
Thomas Braxton King Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 1,583 1,583 (0%) 0% 0 Common Stock
Thomas Braxton King Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 1,583 1,583 - - Stock Options (Right to Buy)
Brandi L. Roberts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 3,165 3,165 - - Stock Options (Right to Buy)
Brandi L. Roberts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 3,165 23,165 (0%) 0% 0 Common Stock
Catherine C. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 1,583 1,583 (0%) 0% 0 Common Stock
Catherine C. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 1,583 1,583 - - Stock Options (Right to Buy)
Harlan F. Weisman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 27,480 27,480 - - Stock Options (Right to Buy)
Harlan F. Weisman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 27,480 842,095 (4%) 0% 0 Common Stock
Kirk Coleman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 10,184 45,859 (0%) 0% 0 Common Stock
Kirk Coleman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 10,184 10,184 - - Stock Options (Right to Buy)
Zamaneh Mikhak Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 10,184 145,184 (0%) 0% 0 Common Stock
Zamaneh Mikhak Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jul 2024 10,184 10,184 - - Stock Options (Right to Buy)
Robert S. Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 4,667 4,667 - - Restricted stock units
Stephen C. Rocamboli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 4,667 4,667 - - Restricted stock units
Thomas Braxton King Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 3,110 3,110 - - Restricted stock units
Brandi L. Roberts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 5,333 5,333 - - Restricted stock units
Catherine C. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 3,556 3,556 - - Restricted stock units
Harlan F. Weisman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 44,967 44,967 - - Restricted stock units
Kirk Coleman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 5,300 5,300 - - Restricted stock units
Kirk Coleman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 10,600 10,600 - - Restricted stock units
Zamaneh Mikhak Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 5,300 5,300 - - Restricted stock units
Zamaneh Mikhak Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 10,600 10,600 - - Restricted stock units
Michael Patane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Apr 2024 3,556 3,556 - - Restricted stock units
Patane Michael Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 132,442 132,442 - - Stock Options (Right to Buy)
Roberts L. Brandi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 52,858 52,858 - - Stock Options (Right to Buy)
S. Robert Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 52,858 52,858 - - Stock Options (Right to Buy)
C. Rocamboli Stephen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 52,858 52,858 - - Stock Options (Right to Buy)
C. Lee Catherine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 132,442 132,442 - - Stock Options (Right to Buy)
Robert S. Mills Director Purchase of securities on an exchange or from another person at price $ 0.25 per share. 15 Aug 2023 40,000 55,980 (0%) 0% 0.3 10,000 Common Stock
Stephen C. Rocamboli Director Purchase of securities on an exchange or from another person at price $ 0.25 per share. 15 Aug 2023 20,000 36,000 (0%) 0% 0.3 5,000 Common Stock
Brandi L. Roberts Director Purchase of securities on an exchange or from another person at price $ 0.25 per share. 15 Aug 2023 20,000 20,000 (0%) 0% 0.3 5,000 Common Stock
Harlan F. Weisman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.25 per share. 15 Aug 2023 600,000 814,615 (4%) 3% 0.3 150,000 Common Stock
Kirk Coleman Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.25 per share. 15 Aug 2023 20,000 35,675 (0%) 0% 0.3 5,000 Common Stock
Zamaneh Mikhak Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.25 per share. 15 Aug 2023 120,000 135,000 (0%) 0% 0.3 30,000 Common Stock
Kirk Coleman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Mar 2023 100,000 100,000 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Purchase of securities on an exchange or from another person at price $ 0.80 per share. 10 Mar 2023 13,000 16,000 (0%) 0% 0.8 10,433 Common Stock
Harlan F. Weisman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.88 per share. 10 Mar 2023 150,000 214,615 (1%) 0% 0.9 131,835 Common Stock
Kirk Coleman Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.79 per share. 10 Mar 2023 12,000 15,675 (0%) 0% 0.8 9,457 Common Stock
Zamaneh Mikhak Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.82 per share. 10 Mar 2023 15,000 15,000 (0%) 0% 0.8 12,300 Common Stock
Harlan F. Weisman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 1.06 per share. 15 Dec 2022 50,000 64,615 (0%) 0% 1.1 53,000 Common Stock
Harlan F. Weisman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2022 1,792,450 1,792,450 - - Stock Options (Right to Buy)
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 1.15 per share. 22 Nov 2022 43,470 143,470 (0%) 0% 1.2 49,991 Common Stock
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Nov 2022 21,735 21,735 - - Common Stock Purchase Warrants
Ralph H. Thurman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Sep 2022 40,255 84,670 - - Stock Options (Right to Buy)
Ralph H. Thurman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 29 Sep 2022 40,255 40,255 (0%) 0% 2.5 100,638 Common Stock
Ralph H. Thurman Director Sale of securities on an exchange or to another person at price $ 4.29 per share. 29 Sep 2022 40,255 0 (0%) 0% 4.3 172,694 Common Stock
Harlan F. Weisman Director Purchase of securities on an exchange or from another person at price $ 5.50 per share. 18 May 2022 4,615 14,615 (0%) 0% 5.5 25,383 Common Stock
Harlan F. Weisman Director Purchase of securities on an exchange or from another person at price $ 5.12 per share. 18 May 2022 2,500 10,000 (0%) 0% 5.1 12,800 Common Stock
Stephen C. Rocamboli Director Purchase of securities on an exchange or from another person at price $ 4.54 per share. 16 May 2022 3,000 18,722 (0%) 0% 4.5 13,620 Common Stock
Glenn Mattes Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.78 per share. 16 May 2022 16,000 36,000 (0%) 0% 4.8 76,480 Common Stock
Harlan F. Weisman Director Purchase of securities on an exchange or from another person at price $ 4.74 per share. 16 May 2022 2,500 7,500 (0%) 0% 4.7 11,850 Common Stock
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 4.86 per share. 16 May 2022 85,000 85,000 (0%) 0% 4.9 413,100 Common Stock
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 5.08 per share. 16 May 2022 24,600 109,600 (0%) 0% 5.1 124,968 Common Stock
Kirk Coleman Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.83 per share. 16 May 2022 425 3,675 (0%) 0% 4.8 2,053 Common Stock
Kirk Coleman Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.40 per share. 16 May 2022 1,250 3,250 (0%) 0% 4.4 5,500 Common Stock
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 6.89 per share. 04 Apr 2022 42,000 542,000 (2%) 0% 6.9 289,380 Common Stock
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 6.43 per share. 04 Apr 2022 500,000 500,000 (2%) 2% 6.4 3,215,000 Common Stock
Christopher Cano Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2021 43,000 200,000 - - Stock Option (Right to Buy)
Glenn Mattes Director, President and CEO Purchase of securities on an exchange or from another person at price $ 7.10 per share. 16 Sep 2021 10,000 20,000 (0%) 0% 7.1 71,000 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Purchase of securities on an exchange or from another person at price $ 7.30 per share. 16 Sep 2021 1,000 2,000 (0%) 0% 7.3 7,300 Common Stock
Malcolm Fairbairn Director Purchase of securities on an exchange or from another person at price $ 8.95 per share. 19 May 2021 10,000 10,000 (0%) 0% 9.0 89,500 Common Stock
Ralph H. Thurman Director Purchase of securities on an exchange or from another person at price $ 9.40 per share. 18 May 2021 1,050 1,050 (0%) 0% 9.4 9,870 Common Stock
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 15 Mar 2021 5,250 35,728 (0%) 0% 5 26,250 Common Stock
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 5,250 102,423 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 14,756 107,673 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Sale of securities on an exchange or to another person at price $ 16.85 per share. 15 Mar 2021 20,006 15,722 (0%) 0% 16.8 337,101 Common Stock
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 15 Mar 2021 14,756 30,478 (0%) 0% 2.5 36,890 Common Stock
Glenn Mattes Director, President and CEO Sale of securities on an exchange or to another person at price $ 17.04 per share. 15 Mar 2021 50,000 10,000 (0%) 0% 17.0 852,000 Common Stock
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 50,000 944,227 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 15 Mar 2021 50,000 60,000 (0%) 0% 2.5 125,000 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 15 Mar 2021 5,000 6,000 (0%) 0% 2.5 12,500 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Sale of securities on an exchange or to another person at price $ 17.05 per share. 15 Mar 2021 5,000 1,000 (0%) 0% 17.1 85,250 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2021 5,000 277,883 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 16 Feb 2021 40,000 50,000 (0%) 0% 2.5 100,000 Common Stock
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2021 40,000 994,227 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Sale of securities on an exchange or to another person at price $ 16.82 per share. 16 Feb 2021 40,000 10,000 (0%) 0% 16.8 672,800 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2021 5,000 282,883 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary and Treasurer Sale of securities on an exchange or to another person at price $ 16.82 per share. 16 Feb 2021 5,000 1,000 (0%) 0% 16.8 84,100 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 16 Feb 2021 5,000 6,000 (0%) 0% 2.5 12,500 Common Stock
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 10 Feb 2021 700 16,680 (0%) 0% 2.5 1,750 Common Stock
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2021 700 151,319 - - Stock Options (Right to Buy)
Robert S. Mills Director Sale of securities on an exchange or to another person at price $ 20.16 per share. 10 Feb 2021 700 15,980 (0%) 0% 20.2 14,112 Common Stock
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 19 Jan 2021 55,100 71,080 (0%) 0% 2.5 137,750 Common Stock
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2021 12,600 152,019 - - Stock Options (Right to Buy)
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2021 55,100 164,619 - - Stock Options (Right to Buy)
Robert S. Mills Director Sale of securities on an exchange or to another person at price $ 20.20 per share. 19 Jan 2021 12,600 15,980 (0%) 0% 20.2 254,520 Common Stock
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 19 Jan 2021 12,600 28,580 (0%) 0% 2.5 31,500 Common Stock
Robert S. Mills Director Sale of securities on an exchange or to another person at price $ 19.56 per share. 19 Jan 2021 55,100 15,980 (0%) 0% 19.6 1,077,756 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2021 5,000 287,883 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary and Treasurer Sale of securities on an exchange or to another person at price $ 17.50 per share. 15 Jan 2021 5,000 1,000 (0%) 0% 17.5 87,500 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 15 Jan 2021 5,000 6,000 (0%) 0% 2.5 12,500 Common Stock
Glenn Mattes Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.33 per share. 23 Dec 2020 30,000 10,000 (0%) 0% 15.3 459,900 Common Stock
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2020 30,000 1,074,227 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 23 Dec 2020 30,000 40,000 (0%) 0% 2.5 75,000 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Sale of securities on an exchange or to another person at price $ 15.24 per share. 23 Dec 2020 10,000 1,000 (0%) 0% 15.2 152,400 Common Stock
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2020 10,000 292,883 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 23 Dec 2020 10,000 11,000 (0%) 0% 2.5 25,000 Common Stock
Robert S. Mills Director Sale of securities on an exchange or to another person at price $ 14.58 per share. 11 Dec 2020 22,794 15,980 (0%) 0% 14.6 332,337 Common Stock
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2020 22,794 219,719 - - Stock Options (Right to Buy)
Robert S. Mills Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 11 Dec 2020 22,794 38,774 (0%) 0% 2.5 56,985 Common Stock
James Brian Windsor Director, Chief Science Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 07 Dec 2020 25,000 30,000 (0%) 0% 2.5 62,500 Common Stock
James Brian Windsor Director, Chief Science Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Dec 2020 25,000 134,429 - - Stock Options (Right to Buy)
James Brian Windsor Director, Chief Science Officer Sale of securities on an exchange or to another person at price $ 15.80 per share. 07 Dec 2020 25,000 5,000 (0%) 0% 15.8 395,000 Common Stock
Aaron Fletcher Director Purchase of securities on an exchange or from another person at price $ 15.13 per share. 24 Nov 2020 5,000 100,000 (0%) 0% 15.1 75,656 Common Stock
Randy H. Thurman Director Sale of securities on an exchange or to another person at price $ 15.91 per share. 11 Nov 2020 34,504 5,000 (0%) 0% 15.9 548,890 Common Stock
Randy H. Thurman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Nov 2020 34,504 124,925 - - Stock Options (Right to Buy)
Randy H. Thurman Director Sale of securities on an exchange or to another person at price $ 17.17 per share. 11 Nov 2020 5,000 0 (0%) 0% 17.2 85,865 Common Stock
Randy H. Thurman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 11 Nov 2020 34,504 39,504 (0%) 0% 2.5 86,260 Common Stock
Malcolm Fairbairn Director Sale of securities on an exchange or to another person at price $ 15.97 per share. 11 Nov 2020 11,669 0 (0%) 0% 16.0 186,307 Common Stock
Malcolm Fairbairn Director Sale of securities on an exchange or to another person at price $ 15.93 per share. 11 Nov 2020 63,331 11,669 (0%) 0% 15.9 1,008,926 Common Stock
Stephen C. Rocamboli Director Sale of securities on an exchange or to another person at price $ 15.76 per share. 10 Nov 2020 15,722 0 (0%) 0% 15.8 247,732 Common Stock
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 10 Nov 2020 21,278 21,278 (0%) 0% 2.5 53,195 Common Stock
Stephen C. Rocamboli Director Sale of securities on an exchange or to another person at price $ 15.14 per share. 10 Nov 2020 21,278 0 (0%) 0% 15.1 322,106 Common Stock
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 10 Nov 2020 15,722 15,722 (0%) 0% 2.5 39,305 Common Stock
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2020 21,278 138,151 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2020 15,722 122,429 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.00 per share. 10 Nov 2020 108,830 10,000 (0%) 0% 15.0 1,631,906 Common Stock
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 10 Nov 2020 108,830 118,830 (0%) 0% 2.5 272,075 Common Stock
Glenn Mattes Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2020 108,830 1,104,227 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary, and Treasurer Sale of securities on an exchange or to another person at price $ 15.12 per share. 10 Nov 2020 15,000 1,000 (0%) 0% 15.1 226,755 Common Stock
Kirk Coleman CFO, Secretary, and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. 10 Nov 2020 15,000 16,000 (0%) 0% 2.5 37,500 Common Stock
Kirk Coleman CFO, Secretary, and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2020 15,000 302,883 - - Stock Options (Right to Buy)
Randy H. Thurman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 20,000 159,429 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 20,000 159,429 - - Stock Options (Right to Buy)
Harlan F. Weisman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 20,000 159,429 - - Stock Options (Right to Buy)
Aaron Fletcher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 20,000 159,429 - - Stock Options (Right to Purchase)
Kirk Coleman CFO, Secretary, and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 40,000 317,883 - - Stock Options (Right to Buy)
James Brian Windsor Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 20,000 159,429 - - Stock Options (Right to Buy)
Malcolm Fairbairn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2020 13,200 105,455 - - Stock Options (Right to Buy)
Aaron Fletcher Director Purchase of securities on an exchange or from another person at price $ 5.08 per share. 26 May 2020 20,000 95,000 (0%) 0% 5.1 101,600 Common Stock
Aaron Fletcher Director Purchase of securities on an exchange or from another person at price $ 4.72 per share. 15 Apr 2020 5,581 75,000 (0%) 0% 4.7 26,342 Common Stock
Aaron Fletcher Director Purchase of securities on an exchange or from another person at price $ 3.75 per share. 02 Apr 2020 500 46,419 (0%) 0% 3.8 1,875 Common Stock
Aaron Fletcher Director Purchase of securities on an exchange or from another person at price $ 4.24 per share. 02 Apr 2020 6,252 69,419 (0%) 0% 4.2 26,508 Common Stock
Aaron Fletcher Director Purchase of securities on an exchange or from another person at price $ 3.97 per share. 02 Apr 2020 16,748 63,167 (0%) 0% 4.0 66,490 Common Stock
Malcolm Fairbairn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2020 92,255 92,255 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary, and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2019 50,000 277,883 - - Stock Options (Right to Buy)
Ralph H. Thurman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 3,623 139,429 - - Stock Options (Right to Buy)
Robert S. Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 2,351 186,374 - - Stock Options (Right to Buy)
Robert S. Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 30,300 242,512 - - Stock Options (Right to Buy)
Robert S. Mills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 25,838 212,212 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 3,623 139,429 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 25,214 971,105 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 152,000 1,213,057 - - Stock Options (Right to Buy)
Glenn Mattes Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 89,952 1,061,057 - - Stock Options (Right to Buy)
Harlan F. Weisman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 3,623 139,429 - - Stock Options (Right to Buy)
Aaron G.L. Fletcher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 3,623 139,429 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary, and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 5,920 227,883 - - Stock Options (Right to Buy)
James Brian Windsor Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2019 3,623 139,429 - - Stock Options (Right to Buy)
Stephen C. Rocamboli Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Oct 2019 43,794 135,806 - - Stock Options (Right to Buy)
Ralph H. Thurman Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 5,000 5,000 (0%) 0% 5 25,000 Common Stock
Ralph H. Thurman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 43,794 135,806 - - Stock Options (Right to Buy)
Robert S. Mills Director 25 Oct 2019 10,980 184,023 - - Series A Preferred Stock
Robert S. Mills Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 5,000 5,000 (0%) 0% 5 25,000 Common Stock
Robert S. Mills Director 25 Oct 2019 10,980 15,980 (0%) 0% - Common Stock
Glenn Mattes Director, President and CEO Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 10,000 10,000 (0%) 0% 5 50,000 Common Stock
Glenn Mattes Director, President and CEO Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 10,000 10,000 (0%) 0% 5 50,000 Common Stock
Glenn Mattes Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 332,868 945,891 - - Stock Options (Right to Buy)
Harlan F. Weisman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 43,794 135,806 - - Stock Options (Right to Buy)
Harlan F. Weisman Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 5,000 5,000 (0%) 0% 5 25,000 Common Stock
Aaron G.L. Fletcher Director 25 Oct 2019 43,919 45,919 (0%) 0% - Common Stock
Aaron G.L. Fletcher Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 2,000 2,000 (0%) 0% 5 10,000 Common Stock
Aaron G.L. Fletcher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 43,794 179,693 - - Warrants
Aaron G.L. Fletcher Director 25 Oct 2019 43,919 135,806 - - Series A Preferred Stock
Kirk Coleman CFO, Secretary, and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 71,963 221,963 - - Stock Options (Right to Buy)
Kirk Coleman CFO, Secretary, and Treasurer Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 1,000 1,000 (0%) 0% 5 5,000 Common Stock
James Brian Windsor Director, Chief Science Officer Purchase of securities on an exchange or from another person at price $ 5.00 per share. 25 Oct 2019 5,000 5,000 (0%) 0% 5 25,000 Common Stock
James Brian Windsor Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 43,794 135,806 - - Stock Options (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters